ifosfamide has been researched along with Obesity in 2 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Excerpt | Relevance | Reference |
---|---|---|
"In summary, female sex, low total bilirubin, albumin and haemoglobin levels, and obesity appear to be associated with ifosfamide-induced encephalopathy." | 4.84 | Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature. ( Beri, R; Shord, SS; Sweiss, KI, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sweiss, KI | 1 |
Beri, R | 1 |
Shord, SS | 1 |
Lind, MJ | 1 |
Margison, JM | 1 |
Cerny, T | 1 |
Thatcher, N | 1 |
Wilkinson, PM | 1 |
1 review available for ifosfamide and Obesity
Article | Year |
---|---|
Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
Topics: Adult; Albumins; Antineoplastic Agents, Alkylating; Bilirubin; Brain Diseases; Cohort Studies; Enzym | 2008 |
1 other study available for ifosfamide and Obesity
Article | Year |
---|---|
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chromat | 1989 |